Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Gullberg & Jansson | GJAB | May 17, 2024 | 18.00 | +9.09 |
H&D Wireless Sweden Holding B | HDWB | May 17, 2024 | 0.02 | +20.00 |
H&M B | HMB | May 17, 2024 | 181.30 | +3.39 |
HAKI Safety A | HAKIA | May 17, 2024 | 28.00 | +7.69 |
HAKI Safety B | HAKIB | May 17, 2024 | 28.10 | +3.69 |
Hamlet BioPharma AB (publ) | HAMLETB | May 17, 2024 | 4.49 | +10.32 |
Hansa Biopharma | HNSA | May 17, 2024 | 36.50 | -3.03 |
Hanza AB | HANZA | May 17, 2024 | 58.25 | +3.10 |
Harm Reduction Group | NOHARM | May 17, 2024 | 0.15 | +7.80 |
Havsfrun Investment | HAVS | May 17, 2024 | 12.40 | -4.98 |
Havsfrun Investment B | HAVB | May 17, 2024 | 12.40 | -4.98 |
Haypp Group | HAYPP | May 17, 2024 | 83.40 | -2.80 |
Headsent | VIMAB | May 17, 2024 | 9.64 | -2.63 |
Heba B | HEBAB | May 17, 2024 | 34.15 | -0.29 |
Hedera Group | HEGR | May 17, 2024 | 5.70 | 0.00 |
Heimstaden Pref | HEIMPREF | May 17, 2024 | 12.04 | +1.86 |
Heliospectra | HELIO | May 17, 2024 | 0.53 | 0.00 |
Hemnet Group | HEM | May 17, 2024 | 303.40 | +1.00 |
Hemply Balance | HMPLY | May 17, 2024 | 0.03 | +6.25 |
Hexagon B | HEXAB | May 17, 2024 | 118.35 | -1.83 |
Hexagon Purus | HPURO | May 17, 2024 | 6.93 | 0.00 |
Hexatronic Group | HTRO | May 17, 2024 | 41.79 | -0.88 |
Hexicon | HEXI | May 17, 2024 | 0.57 | +1.79 |
Hexpol B | HPOLB | May 17, 2024 | 127.60 | -0.08 |
Hifab B | HIFAB | May 17, 2024 | 2.88 | +1.41 |
High Coast Distillery B | HIGHCOB | May 17, 2024 | 45.80 | 0.00 |
Hilbert | HILBB | May 17, 2024 | 4.35 | +3.57 |
HMS Networks | HMS | May 17, 2024 | 463.60 | +0.39 |
Hoegh Autoliners ASA | HAUTOO | May 17, 2024 | 115.90 | 0.00 |
Hoi Publishing AB | HOIB | May 17, 2024 | 0.36 | -10.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.